Blackstone’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Hold
2,681,922
– – 0.03% 90
2026
Q1
$11.1M Hold
2,681,922
– – 0.04% 81
2025
Q4
$10.7M Buy
+2,681,922
New +$9.7M 0.03% 96

Other funds holding XFOR

Blackstone's XFOR Position: Q2 2026 in Review

Blackstone held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 2,681,922 shares worth $12.5M. The position accounts for 0.03% of the portfolio, ranked #90.

Blackstone first reported a position in XFOR in Q4 2025 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Blackstone held 2,681,922 shares of X4 Pharmaceuticals worth $12.5M as of Q2 2026.
  • Blackstone left its X4 Pharmaceuticals share count unchanged in Q2 2026.
  • X4 Pharmaceuticals made up 0.03% of Blackstone's portfolio in Q2 2026, its #90 holding.
  • Blackstone first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.